| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP & Chief Science Officer | SVP & Chief Science Officer
1 company
Alessandra Pavesio last filed a Form 4 in April 2022, as SVP & Chief Science Officer at BVS. Alessandra Pavesio's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 148,309 shares of BVS. The BVS filings lean toward selling, a net 32,430 shares.
Alessandra Pavesio has 7 Form 4 filings on record from February 2021 to April 2022, all as SVP & Chief Science Officer at Bioventus (BVS), 2021–2022.
The 12 reported transactions were 5 option or other derivative awards, 3 option exercises, 2 open-market sales and 1 tax withholding, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $13K and 2 sales worth about $374K.
The only open-market purchase was 1,000 shares of BVS at an average $13.00 on February 11, 2021, about $13K.
The largest open-market sale was 32,997 shares of BVS at an average $11.17 on April 4, 2022, about $368K. Twelve months later BVS was down 92%.
Shares as reported in the last Form 4 for each company; the most recent is from April 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 4, 2022 | BVS Bioventus Inc. | SVP & Chief Science Officer | Sale+OE | 32,997 | $11.17 | $368,424.70 | -18.2% | -43.9% | -91.7% | |
| Feb 14, 2022 | BVS Bioventus Inc. | SVP & Chief Science Officer | Sell | 433 | $11.99 | $5,191.67 | -0.4% | -29.9% | -85.6% | |
| Feb 11, 2021 | BVS Bioventus Inc. | SVP & Chief Science Officer | Buy | 1,000 | $13.00 | $13,000.00 | New | - | - |